2019;365:l1476
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
This allows your provider to determine whether GLP-1 therapy may be appropriate based on your individual goals and medical profile
The Source of Peptides is Crucial The safety of peptides often depends on their origin
Follow the instructions for your exact prescription and contact a qualified healthcare professional for medication, dosing, symptoms, or treatment decisions
For patients with complex metabolic profiles after surgery, the Precision Peptide Genetic Test ($298) maps 14 peptide pathways and identifies genetic variants like GIPR rs1800437, revealing how your genes influence semaglutide response and tolerability